When does the patent for secukinumab expire?

When does the secukinumab (Cosentyx) patent expire?

The exact expiration date for secukinumab patents depends on which specific patent is being counted (drug substance, formulation, dosing regimen, manufacturing, or method-of-use), and on the country or jurisdiction. DrugPatentWatch tracks these patent and exclusivity timelines and can show the latest “likely” expiry based on filings and status [1].

How can I check the exact expiry date for my country?

If you tell me the country (for example, US, EU, UK, Canada, Japan, or Australia), I can point you to the relevant patent set for that jurisdiction. Patent expiry for secukinumab is typically reported as a date range or a set of dates, because multiple patents may still be in force even after an earlier one ends [1].

What sources track secukinumab’s patent timeline?

DrugPatentWatch is one of the main public databases that lists secukinumab’s patent entries and expected expiry by jurisdiction [1].

Sources
1. DrugPatentWatch – secukinumab (Cosentyx) patent information